Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. - Wikidata - awgldk - TriplyDB

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.

http://www.wikidata.org/entity/Q43562457

about

Innate immunity against Leishmania infections The host-protective effect of arabinosylated lipoarabinomannan against Leishmania donovani infection is associated with restoration of IFN-γ responsiveness Crosstalk between purinergic receptors and lipid mediators in leishmaniasis Deception and manipulation: the arms of leishmania, a successful parasite NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.Enhanced expression of Toll-like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis.Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?RNA-seq analysis reveals significant transcriptome changes in turbot (Scophthalmus maximus) suffering severe enteromyxosis.Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2-Cytosolic Phospholipase A2 Signaling.Insights on adaptive and innate immunity in canine leishmaniosis.TLR-CD40 Cross-Talk in Anti-Leishmanial Immune Response.Leishmania and the macrophage: a multifaceted interaction.Toll-like receptor signaling in parasitic infections.Leishmania donovani influenced cytokines and Toll-like receptors expression among Sudanese visceral leishmaniasis patients.Redundant and regulatory roles for Toll-like receptors in Leishmania infection.TLRs/NLRs: Shaping the landscape of host immunity.TLR Specific Immune Responses against Helminth Infections.Infection of Human Monocytes with Leishmania infantum Strains Induces a Downmodulated Response when Compared with Infection with Leishmania braziliensis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.

P2860

Q27010187-1DDC5130-C232-4479-ADAF-641FA79712C0 Q27316485-C11E98BA-C0B5-45A4-BEEB-0B60CAC6210C Q28072094-5BB24ECC-4854-47A8-A5D1-FC21A0582661 Q34369161-ABD1DDD6-C4EE-4B3B-B126-B6A940B899FB Q34513470-8427841E-870F-4CC1-AFAA-58BD12EF7B74 Q34580064-1C967ABF-BCD9-4E43-AD36-EB2D48B8D421 Q34992273-C7C0550B-BB6D-4E61-82FA-7D8A82A4CC7F Q35060010-2324039C-221F-4D2A-A03E-B119629B270C Q35631001-5144425D-2809-4A0E-9EA8-5A76A6E971F2 Q35913098-2B25060B-C8B1-4A70-9C76-8FA3173669BE Q36339132-69A5262F-C0F5-41FA-A856-835574B6C296 Q37287185-751BABEE-6296-4E37-9600-E96E5384CA3A Q37605215-F21B01B5-50EE-48F5-A46E-B01B7405BF32 Q38218114-085BED8B-6D3D-4D76-9120-D19A4FD72023 Q38322760-6EE3950A-2B2D-4D68-89D6-4FF8043DECD6 Q38432017-888C1B4A-641A-4BAF-8E6A-26854EBF4F89 Q38873769-0D07F7DC-9406-45AA-A7BF-8D0FF8DFDDD5 Q39435029-52E0466A-BCB3-4221-A5D1-718C3297DDBE Q47570715-87A2C9DD-DA1D-4B0B-BEC7-6DD35FE707E3 Q48145971-4EE454A5-5AEB-448B-9EE0-8EB027A06B55 Q49479299-1EE9E027-4A24-4313-B7F8-EFAC0A008F08 Q50130388-88333CEA-0571-4806-8183-E906285E2C71 Q54229351-933C84B3-AEE9-4FB8-8AA0-33226205AB94

P2860

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.

http://www.wikidata.org/entity/Q43562457

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Leishmania expressed lipophosp ...... ce anti-leishmanial responses.

@en

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor

@nl

type

label

Leishmania expressed lipophosp ...... ce anti-leishmanial responses.

@en

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor

@nl

prefLabel

Leishmania expressed lipophosp ...... ce anti-leishmanial responses.

@en

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor

@nl

P1433

Q43562457-7D522196-B56C-4097-A984-3D67378AFCA2

P1476

Q43562457-DCED41F4-BDDE-409F-9387-D39A53DF221C

P2093

Q43562457-420A9584-C49A-4C37-B138-EA87E5819C5C

Q43562457-5590E31D-30D3-4FF1-8DC7-EA9B95806FBE

Q43562457-85E2DBAA-1DDB-4D11-8E2A-C409269B3564

Q43562457-ADFE9E8C-F7A0-4D4E-9D97-3B227106CAEF

Q43562457-F9E80B46-7238-41C5-80EF-05C0BB6CA8E0

P2860

Q43562457-17E99267-4F8B-4C1A-AAF1-131089D8A181

Q43562457-1B06575A-DC9A-4E8B-8411-91EA35933249

Q43562457-2077767C-BD25-4DAB-92E9-F61A1EEBA3FE

Q43562457-38E45AD4-75A2-49C4-A60D-84027B1F4A72

Q43562457-423B3DA1-B369-4094-9183-2D47277A5E5D

Q43562457-4BFC497D-DA45-4588-99D4-E9A156D1AFCE

Q43562457-4E455C69-0B37-482E-A3A2-64AA07B5E479

Q43562457-6FC9C627-1758-465F-BA42-76473ABA44AC

Q43562457-7F28A157-53C5-4181-8FCB-E1973AA5EF18

Q43562457-91F18A70-4FCE-460D-ACA4-6F8130869237

P304

Q43562457-0845BBC4-613A-42E4-8788-CBD949F680A4

P31

Q43562457-33D6E8AE-11CD-47C7-A81E-B899EB529C36

P356

Q43562457-56BF18C6-66CB-4701-BFCF-D3BC06D0084E

P433

Q43562457-9BC6EF97-0B66-42D6-A0C9-32A93E0DD041

P478

Q43562457-018721CE-8679-4D7A-952C-1FE0C5E57833

P577

Q43562457-20703E56-95CF-416D-AA7D-0FFCA0E5EBF0

P5875

Q43562457-42C06A93-D0FD-41D3-9FA9-94434E16644E

P698

Q43562457-A4CD795C-E57E-4929-8F0E-AD700C8E2615

P921

Q43562457-d9468a5f-41e5-4c44-b5af-c271594eb83f

P932

Q43562457-641CF1E3-E31C-45D5-99E7-2E89D5A72D1A

P356

P1433

Clinical and Experimental Immunology

P1476

Leishmania expressed lipophosp ...... ce anti-leishmanial responses.

@en

P2093

B Saha

http://www.w3.org/2001/XMLSchema#string

H S Chandel

http://www.w3.org/2001/XMLSchema#string

M K Jha

http://www.w3.org/2001/XMLSchema#string

S P Pandey

http://www.w3.org/2001/XMLSchema#string

S Srivastava

http://www.w3.org/2001/XMLSchema#string

P2860

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.

Macrophage deactivation by interleukin 10

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.

Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.

Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice.

P304

403-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12074

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236249575

http://www.w3.org/2001/XMLSchema#string

P698

23600828

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3646439

http://www.w3.org/2001/XMLSchema#string